Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia
- Conditions
- Residual Aphasia
- Interventions
- Device: atDCSDevice: sham tDCS
- Registration Number
- NCT01845129
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The present study assesses whether language functions in patients with residual post-stroke aphasia can be improved by transcranial direct current stimulation administered to the primary motor cortex in the language dominant (left) hemisphere.
- Detailed Description
Patients will participate in two tDCS sessions (atDCS; sham) in a cross-over within subjects design. tDCS or placebo will be administered during simulatneous fMRI to assess neural signatures of the stimulation. Order of stimulation will be counterbalanced between subjects
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 16
- right handedness
- German native speaker
- cerebrovascular stroke in left hemisphere (>6 months)
- mild aphasia (according to Aachen Aphasia Test Battery Classification, Huber et al., 1983)
- residual anomia in naming test (>75 correct responses)
- other current or previous neurological or psychiatric diseases
- alcohol or drug abuse
- MRI contraindication (e.g. magnetic metal, pacemaker, claustrophobia)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description anodal tDCS atDCS atDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex anodal tDCS sham tDCS atDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex sham tDCS atDCS sham tDCS will be administered to the left primary hand motor cortex sham tDCS sham tDCS sham tDCS will be administered to the left primary hand motor cortex
- Primary Outcome Measures
Name Time Method Response latency during picture naming task (max. 80) Change in response latency between assessment 1 (week 1) and assessment 2 (week 2), assessments 1 and 2 are seperated by one week Subjects are assessed in a cross-over design. The primary outcome measure will be assessed twice in each subject, either during placebo ("sham) stimulation or active (anodal) stimulation with transcranial direct current stimulation. Order of stimulation will be counterbalanced across the group.
- Secondary Outcome Measures
Name Time Method Change in neural activity measured by functional magnetic resonance imaging Change in fMRI activity between Assessment 1 (week 1) and Assessment 2 (week 2), assessments 1 and 2 are seperated by one week
Trial Locations
- Locations (1)
Charite, University Medicine, Dept. of Neurology
🇩🇪Berlin, Germany